AVANCE CLINICAL THE CRO FOR BIOTECHS
LIVE

Serial Number

79401298

Owner

Avance Clinical Pty Ltd

Attorney

David L. May

Filing Date

May 24, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AVANCE CLINICAL THE CRO FOR BIOTECHS Trademark

Serial Number: 79401298 • Registration: 7988932

AVANCE CLINICAL THE CRO FOR BIOTECHS is a trademark filed by Avance Clinical Pty Ltd on May 24, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Avance Clinical Pty Ltd (4 trademarks)

213 Glynburn Road

Entity Type: 99

Trademark Details

Filing Date

May 24, 2024

Registration Date

October 21, 2025

Published for Opposition

September 2, 2025

Goods & Services

Advisory services relating to pharmacology; advisory services relating to product testing; advisory services relating to science in the field of pharmacology; advisory services relating to scientific research; development of software systems for the processing of data; development of testing methods in the field of pharmacology; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of pharmacology; conducting technical project studies, namely, conducting scientific feasibility studies in the field of pharmacology; consultancy pertaining to pharmacology; medical research; pharmaceutical research services; preparation of reports relating to scientific research; preparation of statistics for scientific research, namely, preparation of technical reports and analyses of statistical data for scientific research; provision of information relating to scientific research; Product quality testing; research relating to biotechnology; scientific research relating to data processing; research relating to medicine; research relating to pharmaceuticals; scientific and technical analysis in the field of pharmacology; scientific consultancy services relating to pharmacology; scientific testing services inĀ  the field of pharmacology; pharmaceutical testing services for assessing the efficiency of pharmaceuticals; pharmaceutical testing services for assessing the safety of pharmaceuticals; technical data analysis services in the field of pharmacology for scientific research purposes; testing of products

Business statistical analysis; business statistical studies; compilation of statistics for business purposes; data collection for biotechnology and pharmaceutical companies for business purposes; data compilation for others for business purposes; data management services, namely, business information management services for use by biotechnology and pharmaceutical companies for business purposes; data management advice, namely, providing advice in the field of business information management; data management consultancy, namely, consultancy in the field of business information management; data processing services, namely, database management; data capture, namely, computer data entry services; data cleansing services, namely, computer data entry services in the nature of correcting or removing inaccurate or incomplete data from databases; Data processing services, namely, updating and maintenance of data in computer databases; Data processing services, namely, data systemization in computer databases; data processing; data processing verification; Data processing services, namely, data retrieval; Data processing services, namely, data transcription, namely, computer data entry services; demand-based computerised data processing

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 23, 2026 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
May 28, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 7, 2026 FICS
FINAL DISPOSITION PROCESSED
May 7, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 21, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 15, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 31, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 31, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 2, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 27, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 28, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 28, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 28, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 28, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 29, 2025 GNFN
FINAL REFUSAL E-MAILED
May 29, 2025 GNFR
FINAL REFUSAL WRITTEN
May 29, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2025 TROA
REFUSAL PROCESSED BY IB
Jan 25, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 4, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jan 4, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 17, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 16, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 9, 2024 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 13, 2024 ADCH
APPLICATION FILING RECEIPT MAILED
Aug 6, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 1, 2024 REPR